C M Bidwell & Associates LTD Eagle Pharmaceuticals, Inc. Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $825 - $1,027	-20 Reduced 2.13%	920 $41,000
Q4 2021 Feb 11, 2022	BUY	$45.82 - $56.9 $43,070 - $53,486	940 New	940 $48,000
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $22,399 - $41,315	-610 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $40,656 - $51,154	610 New	610 $42,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.